Filing Flows › Arbutus Biopharma (ABUS) › Collaborations and licenses revenue
Arbutus Biopharma (ABUS) Collaborations and licenses revenue by quarter
Arbutus Biopharma's Collaborations and licenses revenue was $202K in Q2 2026 (second quarter 2026), -1% from Q1 2026. Over the last 7 quarters it ranged from $202K (Q2 2026) to $10.2M (Q2 2025).
| Quarter | Collaborations and licenses revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $202K | -1% | -98% |
| Q1 2026 | $204K | -74% | -84% |
| Q4 2025 | $792K | +183% | -25% |
| Q3 2025 | $280K | -97% | — |
| Q2 2025 | $10.2M | +676% | — |
| Q1 2025 | $1.3M | +24% | — |
| Q4 2024 | $1.1M | — | — |
Q2 2026 at a glance
Arbutus Biopharma, Q2 2026: revenue $1.0M (-91% year over year), operating margin -588.2%, net loss $5.1M, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arbutus Biopharma's Collaborations and licenses revenue?
Arbutus Biopharma's Collaborations and licenses revenue was $202K in Q2 2026 (second quarter 2026), -1% from Q1 2026.
How has Arbutus Biopharma's Collaborations and licenses revenue changed?
Over the last 7 quarters it ranged from $202K (Q2 2026) to $10.2M (Q2 2025).